WO2013103792A3 - Procédé de traitement du cancer par administration de faibles taux de protéine de choc thermique 70 (hsp70) - Google Patents

Procédé de traitement du cancer par administration de faibles taux de protéine de choc thermique 70 (hsp70) Download PDF

Info

Publication number
WO2013103792A3
WO2013103792A3 PCT/US2013/020252 US2013020252W WO2013103792A3 WO 2013103792 A3 WO2013103792 A3 WO 2013103792A3 US 2013020252 W US2013020252 W US 2013020252W WO 2013103792 A3 WO2013103792 A3 WO 2013103792A3
Authority
WO
WIPO (PCT)
Prior art keywords
hsp70
administration
heat shock
treating cancer
shock protein
Prior art date
Application number
PCT/US2013/020252
Other languages
English (en)
Other versions
WO2013103792A2 (fr
Inventor
John Mcmichael
Original Assignee
Beech Tree Labs, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beech Tree Labs, Inc. filed Critical Beech Tree Labs, Inc.
Priority to JP2014551330A priority Critical patent/JP2015515445A/ja
Priority to CA2858427A priority patent/CA2858427A1/fr
Priority to EP13733755.6A priority patent/EP2800577A2/fr
Priority to AU2013207466A priority patent/AU2013207466A1/en
Publication of WO2013103792A2 publication Critical patent/WO2013103792A2/fr
Priority to IL232732A priority patent/IL232732A0/en
Publication of WO2013103792A3 publication Critical patent/WO2013103792A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

L'invention concerne des procédés de traitement du cancer par administration de protéine de choc thermique 70 (Hsp70) au sujet atteint de cancer.
PCT/US2013/020252 2012-01-05 2013-01-04 Procédé de traitement du cancer par administration de faibles taux de protéine de choc thermique 70 (hsp70) WO2013103792A2 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2014551330A JP2015515445A (ja) 2012-01-05 2013-01-04 低レベルの熱ショックタンパク質７０（Ｈｓｐ７０）を投与することによって癌を処置する方法
CA2858427A CA2858427A1 (fr) 2012-01-05 2013-01-04 Procede de traitement du cancer par administration de faibles taux de proteine de choc thermique 70 (hsp70)
EP13733755.6A EP2800577A2 (fr) 2012-01-05 2013-01-04 Procédé de traitement du cancer par administration de faibles taux de protéine de choc thermique 70 (hsp70)
AU2013207466A AU2013207466A1 (en) 2012-01-05 2013-01-04 Method of treating cancer by administration of low levels of heat shock protein 70 (Hsp70)
IL232732A IL232732A0 (en) 2012-01-05 2014-05-21 A method of treating cancer by administering low levels of heat shock protein 70

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261583535P 2012-01-05 2012-01-05
US61/583,535 2012-01-05

Publications (2)

Publication Number Publication Date
WO2013103792A2 WO2013103792A2 (fr) 2013-07-11
WO2013103792A3 true WO2013103792A3 (fr) 2015-01-22

Family

ID=48745538

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2013/020252 WO2013103792A2 (fr) 2012-01-05 2013-01-04 Procédé de traitement du cancer par administration de faibles taux de protéine de choc thermique 70 (hsp70)

Country Status (6)

Country Link
EP (1) EP2800577A2 (fr)
JP (1) JP2015515445A (fr)
AU (1) AU2013207466A1 (fr)
CA (1) CA2858427A1 (fr)
IL (1) IL232732A0 (fr)
WO (1) WO2013103792A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202019398A (zh) * 2018-06-28 2020-06-01 張翔毓 用於治療或預防構形疾病之方法及藥物篩選方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396681B1 (en) * 1998-03-27 2008-07-08 Gabriele Multhoff Application of Hsp70 proteins
US20110286993A1 (en) * 2008-06-26 2011-11-24 Orphazyme ApS c/o COBIS A/S Use of hsp70 as a regulator of enzymatic activity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7396681B1 (en) * 1998-03-27 2008-07-08 Gabriele Multhoff Application of Hsp70 proteins
US20110286993A1 (en) * 2008-06-26 2011-11-24 Orphazyme ApS c/o COBIS A/S Use of hsp70 as a regulator of enzymatic activity

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ISHIKAWA ET AL.: "Intratumoral injection of IL -2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model.", CANCER SCI., vol. 95, no. 1, January 2004 (2004-01-01), pages 98 - 103, XP055173453 *

Also Published As

Publication number Publication date
IL232732A0 (en) 2014-07-31
CA2858427A1 (fr) 2013-07-11
AU2013207466A1 (en) 2014-06-12
WO2013103792A2 (fr) 2013-07-11
EP2800577A2 (fr) 2014-11-12
JP2015515445A (ja) 2015-05-28

Similar Documents

Publication Publication Date Title
EP3365062A4 (fr) Procédés de traitement de tumeurs solides ou lymphatiques par polythérapie
WO2015085318A3 (fr) Vaccins adaptatifs ciblés
EP3240551A4 (fr) Méthodes de traitement de troubles hématologiques, de tumeurs solides, ou de maladies infectieuses à l'aide de cellules tueuses naturelles
EP3027192A4 (fr) Méthodes permettant de traiter des tumeurs solides
SG10201908028SA (en) Cyclopropylamines as lsd1 inhibitors
WO2014160465A3 (fr) Particules de modification immunitaire pour le traitement d'inflammation
WO2013056148A3 (fr) Procédés d'utilisation d'antagonistes de scd1
MX362550B (es) Inhibidores ciclicos de glutaminasa.
WO2015054642A3 (fr) Utilisation d'inhibiteurs du bromodomaine de cbp/ep300 pour l'immunothérapie du cancer
HK1220324A1 (zh) 用於治療血管緊張素相關疾病的方法、化合物和組合物
GB201103062D0 (en) Method
EA201690007A1 (ru) Соединения, ингибирующие металлоферменты
WO2015031679A3 (fr) Modulation de l'expression de la prékallikréine (pkk)
IN2014DN06792A (fr)
WO2014151456A3 (fr) Traitement de maladies inflammatoires
HK1215173A1 (zh) 治療金黃色葡萄球菌相關疾病的方法
EA201600026A1 (ru) Бактериальная гиалуронидаза и способ ее производства
WO2014205266A3 (fr) Compositions et méthodes pour la détection et le traitement du glioblastome
AU2018253600A1 (en) Dosage forms and therapeutic uses of l-4-chlorokynurenine
EA201290744A1 (ru) Имидазо[1,2-b][1,2,4]триазины в качестве c-met ингибиторов
WO2015179835A3 (fr) Biomarqueurs mit et leurs méthodes d'utilisation
EA201600288A1 (ru) Замещенные фенилаланиновые производные
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
EP3079679A4 (fr) Procédé de traitement de l'alopécie à l'aide de monoterpénoïdes
EP3362205A4 (fr) Procédés pour améliorer le traitement thermique de pièces coulées

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13733755

Country of ref document: EP

Kind code of ref document: A2

WWE Wipo information: entry into national phase

Ref document number: 232732

Country of ref document: IL

REEP Request for entry into the european phase

Ref document number: 2013733755

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2013733755

Country of ref document: EP

ENP Entry into the national phase

Ref document number: 2858427

Country of ref document: CA

ENP Entry into the national phase

Ref document number: 2013207466

Country of ref document: AU

Date of ref document: 20130104

Kind code of ref document: A

ENP Entry into the national phase

Ref document number: 2014551330

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE